SKYE BIOSCIENCE INC. - COMMON STOCK
3.1000
08-1月-25 16:45:00
15 分の遅延
株式
+0.0300
+0.98%
本日の幅
2.9600 - 3.2500
ISIN
N/A
ソース
NASDAQ
-
Skye Concentrates Strategy and Clinical Development Focus on Nimacimab Metabolic Program
10 6 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Skye Bioscience to Present at Jefferies Global Healthcare Conference
03 6 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
10 5 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
30 4 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Skye Bioscience to Present at Upcoming Investment Conferences
23 4 2024 07:00:00 提供 Nasdaq GlobeNewswire